Literature DB >> 6990880

Drug level monitoring in paediatric practice.

G W Rylance, T A Moreland.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6990880      PMCID： PMC1626686          DOI： 10.1136/adc.55.2.89

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  119 in total

1.  Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors:  I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

2.  Pharmacology of the metabolites of chlordiazepoxide and diazepam.

Authors:  L O Randall; C L Scheckel; R F Banziger
Journal:  Curr Ther Res Clin Exp       Date:  1965-09

3.  Relation of eeg and seizures to phenobarbital in serum.

Authors:  F Buchthal; O Svensmark; H Simonsen
Journal:  Arch Neurol       Date:  1968-12

4.  Concurrent assay of phenobarbital and diphenylhydantoin in plasma by vapor-phase chromatography.

Authors:  J C Van Meter; H S Buckmaster; L L Shelley
Journal:  Clin Chem       Date:  1970-02       Impact factor: 8.327

5.  Disappearance of phenobarbital and diphenylhydantoin from serum of children.

Authors:  L K Garrettson; P G Dayton
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

6.  Dosage of gentamicin for pseudomonas infections.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1967-05-27

7.  The conversion of cortisone to cortisol and prednisone to prednisolone in man.

Authors:  J S Jenkins; P A Sampson
Journal:  Proc R Soc Med       Date:  1966-07

8.  Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.

Authors:  G B Elion; A Kovensky; G H Hitchings
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

9.  [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].

Authors:  H Remmer; J Hirschmann; I Greiner
Journal:  Dtsch Med Wochenschr       Date:  1969-06-13       Impact factor: 0.628

10.  The rate of decline of diphenylhydantoin in human plasma.

Authors:  K Arnold; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.903
View more
  8 in total

1.  Measurement of saliva tacrolimus levels in pediatric renal transplant recipients.

Authors:  Vladimir Belostotsky; Jo Adaway; Brian G Keevil; Dena R Cohen; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2010-10-24       Impact factor: 3.714

2.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

3.  Usefulness of serum levels of phenobarbitone in control of epilepsy.

Authors:  I C Shriyan; R T Bajaj
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

4.  The current status of phenobarbitone use in childhood.

Authors:  R T Bajaj; U V Kolhatkar
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

5.  Saliva carbamazepine and phenytoin level monitoring.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

Review 6.  Time course of trough serum gentamicin concentrations in preterm and term neonates.

Authors:  M A de Cos; J Gómez-Ullate; F Gómez; J A Armijo
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 7.  The role of therapeutic drug monitoring in children.

Authors:  L O Boréus
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 8.  Overview of systematic reviews of therapeutic ranges: methodologies and recommendations for practice.

Authors:  Lewis Cooney; Yoon K Loke; Su Golder; Jamie Kirkham; Andrea Jorgensen; Ian Sinha; Daniel Hawcutt
Journal:  BMC Med Res Methodol       Date:  2017-06-02       Impact factor: 4.615
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.